Ramani Biswarathan, Harris Ginny M, Huang Rogerio, Seki Takahiro, Murphy Geoffrey G, Costa Maria do Carmo, Fischer Svetlana, Saunders Thomas L, Xia Guangbin, McEachin Richard C, Paulson Henry L
Department of Neurology, Medical Scientist Training Program and Neuroscience Graduate Program.
Medical Scientist Training and Cellular and Molecular Biology Graduate Programs, University of Iowa College of Medicine, IA, USA.
Hum Mol Genet. 2015 Mar 1;24(5):1211-24. doi: 10.1093/hmg/ddu532. Epub 2014 Oct 15.
Polyglutamine diseases, including spinocerebellar ataxia type 3 (SCA3), are caused by CAG repeat expansions that encode abnormally long glutamine repeats in the respective disease proteins. While the mechanisms underlying neurodegeneration remain uncertain, evidence supports a proteotoxic role for the mutant protein dictated in part by the specific genetic and protein context. To further define pathogenic mechanisms in SCA3, we generated a mouse model in which a CAG expansion of 82 repeats was inserted into the murine locus by homologous recombination. SCA3 knockin mice exhibit region-specific aggregate pathology marked by intranuclear accumulation of the mutant Atxn3 protein, abundant nuclear inclusions and, in select brain regions, extranuclear aggregates localized to neuritic processes. Knockin mice also display altered splicing of the disease gene, promoting expression of an alternative isoform in which the intron immediately downstream of the CAG repeat is retained. In an independent mouse model expressing the full human ATXN3 disease gene, expression of this alternatively spliced transcript is also enhanced. These results, together with recent findings in other polyglutamine diseases, suggest that CAG repeat expansions can promote aberrant splicing to produce potentially more aggregate-prone isoforms of the disease proteins. This report of a SCA3 knockin mouse expands the repertoire of existing models of SCA3, and underscores the potential contribution of alternative splicing to disease pathogenesis in SCA3 and other polyglutamine disorders.
多聚谷氨酰胺疾病,包括3型脊髓小脑共济失调(SCA3),是由CAG重复序列扩增引起的,这些扩增在相应的疾病蛋白中编码异常长的谷氨酰胺重复序列。虽然神经退行性变的潜在机制仍不确定,但有证据支持突变蛋白的蛋白毒性作用,这部分取决于特定的遗传和蛋白质背景。为了进一步确定SCA3的致病机制,我们构建了一个小鼠模型,通过同源重组将82个重复序列的CAG扩增插入到小鼠基因座中。SCA3基因敲入小鼠表现出区域特异性的聚集病理,其特征是突变的Atxn3蛋白在核内积累、大量核内包涵体,以及在特定脑区,位于神经突过程中的核外聚集物。基因敲入小鼠还表现出疾病基因剪接的改变,促进了一种替代异构体的表达,其中CAG重复序列下游紧邻的内含子被保留。在一个表达完整人类ATXN3疾病基因的独立小鼠模型中,这种选择性剪接转录本的表达也增强。这些结果,连同最近在其他多聚谷氨酰胺疾病中的发现,表明CAG重复序列扩增可促进异常剪接,从而产生可能更易形成聚集物的疾病蛋白异构体。这篇关于SCA3基因敲入小鼠的报告扩展了现有的SCA3模型库,并强调了选择性剪接对SCA3和其他多聚谷氨酰胺疾病发病机制的潜在贡献。